Navigation Links
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Date:3/31/2008

er stopping their current high blood pressure medication, patients received a single-pill combination of either Lotrel or a combination of benazepril and HCTZ. In the first two months of the study, doses of study medications were increased. Patients in the Lotrel arm started on 5/20 mg. The dose was increased to Lotrel 5/40 mg and, for patients not at goal blood pressure, then to 10/40 mg. Patients taking benazepril and HCTZ started at 20/12.5 mg and were increased to 40/12.5 mg and, for patients not at goal blood pressure, to 40/25 mg. The combination doses of benazepril and HCTZ 40/12.5 mg and 40/25 mg used in this study were investigational. In both arms, patients were given additional blood pressure medication if goal blood pressure was not attained on the maximum dose of study medications.

The primary study endpoint was a composite of cardiovascular disease, non- fatal heart attack, non-fatal stroke, and hospitalization for unstable angina (chest pain that occurs when the heart muscle does not get enough blood) or revascularization (a procedure that re-establishes blood flow to previously restricted regions of the heart), and cardiovascular death. The full data will be available later this year and further analyses will examine the effects on specific patient populations.

Important safety information

LOTREL and the fixed dose combination of benazepril and HCTZ are prescription medications for the treatment of high blood pressure. They should not be used before other high blood pressure medications have been tried first.

LOTREL and the fixed dose combination of benazepril and HCTZ can harm an unborn baby and even cause death. If you get pregnant, stop taking LOTREL or the benazepril and HCTZ combination. Call your doctor right away. Talk to your doctor about other ways to lower your blood pressure if you plan to become pregnant.

Don't take LOTREL or the benazepril and HCTZ combination if you are allergic to any of the ingredien
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
2. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
3. New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
4. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
5. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
6. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
7. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
8. New Drug Combination is Able to Eradicate Breast Metastases in Mice
9. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... The International Myeloma Foundation (IMF) – improving ... toward prevention and a cure – today commended Representative ... resolution (H. Res. 174) that supports the designation of ... Awareness Month." Currently there are more than ... 110,000 new cases are diagnosed yearly, according to the ...
(Date:3/27/2015)... March 27, 2015  Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces the reporting of data from a ... for Injection with the Delcath Hepatic Delivery System ... at the Society of Surgical Oncology (SSO) Annual ...
(Date:3/26/2015)... PASADENA, Calif. , March 26, 2015 ... San Gabriel Valley to perform transcatheter aortic valve replacement ... TAVR procedure is a revolutionary new way to replace ... use of a heart lung machine. The ... heart team led by Azhil ( Alex) Durairaj , ...
Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... Pharmaceuticals, Inc. today announced that Thomas Schreck, President & Chief ... will be presenting at the Lazard Capital Markets 6th Annual ... St. Regis Hotel, New York. , AcelRx Pharmaceuticals, presentation ... Time. , Mr. Schreck and Dr. Palmer will be ...
... Walt Maclay, President of Voler Systems ( ... on "Data Acquisition for Medical Devices" at BIOMEDevice,s ... http://www.devicelink.com/expo/biomed09/index.html ) is the premier event ... The show offers a compelling mix of new ...
Cached Medicine Technology:AcelRx to Present at the Lazard 6th Annual Healthcare Conference 2Voler Systems President Speaks at BIOMEDevice San Jose 2Voler Systems President Speaks at BIOMEDevice San Jose 3
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration ... Conference Center in Chesapeake, Virginia. Each year, ARDX celebrates ... in the Hampton Roads region. The 2015 Women’s History ... Women grow stronger through sharing their stories and learning the ... WWC™ theme is T-talk where we will share a cup ...
(Date:3/28/2015)... Servpro of Paso Robles , ... report about the link between mold and asthma. Mold ... to recent medical research, may even cause asthma in ... Protection Agency, people with sensitivity to mold or mold ... trigger asthma attacks for asthma sufferers. The EPA recommends ...
(Date:3/27/2015)... The Monogamy Method - a new ... Jason Rogers has just been released to the public ... surrounding the course's launch has caught the attention of ... review of the new program. , "Many women report ... suddenly start pulling away or expressing interest in other ...
(Date:3/27/2015)... In her mid-forties and with a lifelong ... Monica K. arrived at JET Uniform & Supply ... and scared. The owners and staff at JET, which had ... to offer jobs to challenged residents like Monica, were patient. ... to begin with the end in mind,” says Stephen Milaney, ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 The ... ) that allege the statin medication increases the risk ... granted Pfizer Inc.’s Motion to Dismiss four individual cases ... a Case Management Order issued in the U.S. District ... Court determined that the dismissals were warranted because the ...
Breaking Medicine News(10 mins):Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
... June 23 Protocol Driven Healthcare, Inc. (PDHI) launches ... Process so that organizations can merge historical data from ... HRA. , , Organizations may be reluctant to ... for fear of losing valuable health information accumulated over ...
... women affects function remains unclear, researchers say , TUESDAY, June ... auras have an increased risk of developing brain lesions, a ... damaged brain tissue affect function or cognition, however, remains unknown, ... as episodic, with no trace they,d occurred, but these data ...
... maintain a healthy weight, , TUESDAY, June 23 (HealthDay News) ... the risk for pancreatic cancer, and obesity in middle age ... study finds. , Pancreatic cancer is the fourth leading cause ... States. As the number of people who are overweight and ...
... ... health -- and your life, says cancer survivor Jo Joshua Godfrey, whose family ... thought the healthcare system might have changed since she beat cancer, but last ... knows she is not alone, and she is leading the charge to ...
... ... synergy to meet the health and wellness needs of our nation,s over-the-road drivers and will ... Center June 25-27, 2009. , ... Burtonsville, MD (PRWEB) June 23, 2009 -- Lifeclinic International, Inc., the world,s leading manufacturer and ...
... ... , ... -- This week and throughout the summer, millions of people across the country will respond to ... new initiative launched today titled United We Serve . The United Nations Foundation ...
Cached Medicine News:Health News:PDHI Launches ConXus Profile Third-Party Health Risk Assessment Data-Load Process 2Health News:Migraine With Aura May Lead to Brain Lesions 2Health News:Migraine With Aura May Lead to Brain Lesions 3Health News:Obesity While Young Boosts Pancreatic Cancer Risk 2Health News:Obesity While Young Boosts Pancreatic Cancer Risk 3Health News:Insurance May Be Hazardous to Your Health: "They Figured It Was Cheaper to Kill Me" 2Health News:Insurance May Be Hazardous to Your Health: "They Figured It Was Cheaper to Kill Me" 3Health News:Insurance May Be Hazardous to Your Health: "They Figured It Was Cheaper to Kill Me" 4Health News:Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals 2Health News:Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals 3Health News:The United Nations Foundation Joins White House Initiative to Encourage Public Service 2Health News:The United Nations Foundation Joins White House Initiative to Encourage Public Service 3
... the slight change in the difficulty score ... derived from the best corrected visual acuity ... study. The original charts difficulty scores were ... In addition to the revised arrangement of ...
... The Stereo Tower is used to ... and adults without the use of ... tests can be used for study, testing ... form and depth perception. The instruction card ...
... The Lang Stereotest was created to simplify stereopsis ... principles: random dots and cylindrical gratings. Lang Stereotest ... car 400 and elephant 600 seconds of arc ... II test, the random dots are smaller and ...
... three test plates(6mm, 3mm, and 1.5mm thick), which ... 600 - 15 seconds. No special glasses are ... if stereopsis is present. Test plates can be ... learning the correct answer. Large stereo acuity range. ...
Medicine Products: